<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04158466</url>
  </required_header>
  <id_info>
    <org_study_id>890</org_study_id>
    <nct_id>NCT04158466</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Safety and Efficacy of a Kalifilcon A Contact Lens for Daily Disposable Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable&#xD;
      contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable&#xD;
      contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 247 participants (494 eyes) will be enrolled in at approximately 20&#xD;
      investigative sites in the United States (US). A minimum of 20% of the randomized&#xD;
      participants will be of Japanese descent (for example, both maternal and paternal&#xD;
      grandparents born in Japan).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 31, 2019</start_date>
  <completion_date type="Actual">November 12, 2019</completion_date>
  <primary_completion_date type="Actual">November 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean logMAR Contact Lens Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Visual acuity (VA) will be reported as letters read correctly, and the letters read will be converted to logarithm of the minimum angle of resolution (logMAR) acuity. The participant will read rows of letters on a standard LogMAR chart until the participant misses 3 letters on a row with 5 letters. The total number of correct letters will be recorded. A decrease in the number of correct letters indicates a decrease in visual acuity. Acuity will be averaged across visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of Participants With Slit Lamp Findings Greater Than Grade 2</measure>
    <time_frame>3 months</time_frame>
    <description>During an examination of both eyes without lenses, graded slit lamp findings will be assessed for each eye using Grades 0 (none), 1 (trace), 2 (mild), 3 (moderate), and 4 (severe). Using only the non-missing observations from all visits without imputation, each eye will be classified with respect to findings greater than Grade 2 at any visit (Absent or Present). Epithelial edema, epithelial microcysts, corneal staining, limbal Injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be evaluated.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">252</enrollment>
  <condition>Contact Lens Wear</condition>
  <arm_group>
    <arm_group_label>Kalifilcon A Daily Disposable Contact Lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biotrue ONEday Daily Disposable Contact Lenses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Kalifilcon A Daily Disposable Contact Lenses</intervention_name>
    <description>Contact lens</description>
    <arm_group_label>Kalifilcon A Daily Disposable Contact Lenses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biotrue ONEday Daily Disposable Contact Lenses</intervention_name>
    <description>Contact lens</description>
    <arm_group_label>Biotrue ONEday Daily Disposable Contact Lenses</arm_group_label>
    <other_name>Bausch + Lomb Biotrue ONEday® Daily Contact Lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants must be able to read, understand, and provide written informed consent on&#xD;
             the Institutional Review Board (IRB) approved Informed Consent Form (ICF) and provide&#xD;
             authorization as appropriate for local privacy regulations.&#xD;
&#xD;
          -  Participants must be myopic and require lens correction from -0.25 to -6.00 Diopter&#xD;
             (D) with 0.25 D steps, in each eye.&#xD;
&#xD;
          -  Participants must be correctable through spherocylindrical refraction and with soft&#xD;
             spherical contact lenses to 40 letters (0.14 logMAR) or better (2 meters distance,&#xD;
             high-contrast chart) in each eye.&#xD;
&#xD;
          -  Participants must be free of any anterior segment disorders.&#xD;
&#xD;
          -  Participants must be adapted soft contact lens wearers and willing to wear their study&#xD;
             lenses for at least 8 hours per day at least 5 days per week on a daily disposable&#xD;
             wear basis for approximately 3 months.&#xD;
&#xD;
          -  Participants must be willing and able to comply with all treatment and follow-up/study&#xD;
             procedures, as well as willing and able to refrain from using any other contact lenses&#xD;
             or solutions other than those provided for the duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in any drug or device clinical investigation within 2 weeks prior to&#xD;
             entry into this study (Screening/Dispensing Visit) and/or during the period of study&#xD;
             participation.&#xD;
&#xD;
          -  Participants who are women of childbearing potential (those who are not surgically&#xD;
             sterilized or postmenopausal) are excluded from participation in the investigation if&#xD;
             they are currently pregnant, plans to become pregnant during the study, or is&#xD;
             breastfeeding&#xD;
&#xD;
          -  Participants who have worn gas permeable (GP) contact lenses within the last 30 days&#xD;
             or who have worn polymethylmethacrylate (PMMA) lenses within the last 3 months.&#xD;
&#xD;
          -  Participants with any systemic disease currently affecting ocular health or in the&#xD;
             Investigator's opinion may have an effect on ocular health during the course of the&#xD;
             study.&#xD;
&#xD;
          -  Participants using any systemic or topical medications that will, in the&#xD;
             Investigator's opinion, affect ocular physiology or lens performance.&#xD;
&#xD;
          -  Participants with an active ocular disease or who are using any ocular medication.&#xD;
&#xD;
          -  Participants who currently wear monovision, multifocal, or toric contact lenses.&#xD;
&#xD;
          -  Participants with an ocular astigmatism of greater than 1.00 D in either eye.&#xD;
&#xD;
          -  Participants with anisometropia (spherical equivalent) of greater than 2.00 D.&#xD;
&#xD;
          -  Participants with any Grade 2 or greater finding during the slit lamp examination.&#xD;
             Participants with corneal infiltrates of any grade.&#xD;
&#xD;
          -  Participants with any &quot;Present&quot; finding during the slit lamp examination that, in the&#xD;
             Investigator's judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Participants with any scar or neovascularization within the central 6 millimeters (mm)&#xD;
             of the cornea.&#xD;
&#xD;
          -  Participants who are aphakic.&#xD;
&#xD;
          -  Participants who are amblyopic.&#xD;
&#xD;
          -  Participants who have had any corneal surgery (for example, refractive surgery).&#xD;
&#xD;
          -  Participants who are allergic to any component in the study care products.&#xD;
&#xD;
          -  The participant is an employee of the investigative site.&#xD;
&#xD;
          -  The participant, or a member of the participant's household, is an Ophthalmologist, an&#xD;
             Optometrist, an Optician, or an Ophthalmic Assistant/Technician.&#xD;
&#xD;
          -  The participant, or a member of the participant's household, is an employee of a&#xD;
             manufacturer of contact lenses or contact lens care products (for example, Alcon,&#xD;
             Bausch + Lomb, Ciba Vision, CooperVision, Johnson &amp; Johnson).&#xD;
&#xD;
          -  The participant, or a member of the participant's household, is an employee of a&#xD;
             market research firm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Donatello</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch Site 8</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 9</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 10</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 12</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 6</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 4</name>
      <address>
        <city>'Aiea</city>
        <state>Hawaii</state>
        <zip>96701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 16</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 7</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 11</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 1</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 13</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <zip>13850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 2</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 14</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 5</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 3</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bausch Site 15</name>
      <address>
        <city>New Berlin</city>
        <state>Wisconsin</state>
        <zip>53151</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>November 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <results_first_submitted>October 26, 2020</results_first_submitted>
  <results_first_submitted_qc>October 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 19, 2020</results_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Disposable Contact Lenses</keyword>
  <keyword>Soft Contact Lens</keyword>
  <keyword>Soft Contact Lenses</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04158466/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>There were 252 participants randomized but 251 participants received treatment. Participants are summarized by actual treatment group received.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Kalifilcon A Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Kalifilcon A Daily Disposable Contact Lenses: Contact lens</description>
        </group>
        <group group_id="P2">
          <title>Biotrue ONEday Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Biotrue ONEday Daily Disposable Contact Lenses: Contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="124"/>
                <participants group_id="P2" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="121"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants are summarized by actual treatment group received.</population>
      <group_list>
        <group group_id="B1">
          <title>Kalifilcon A Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Kalifilcon A Daily Disposable Contact Lenses: Contact lens</description>
        </group>
        <group group_id="B2">
          <title>Biotrue ONEday Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Biotrue ONEday Daily Disposable Contact Lenses: Contact lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="124"/>
            <count group_id="B2" value="127"/>
            <count group_id="B3" value="251"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.9" lower_limit="18" upper_limit="54"/>
                    <measurement group_id="B2" value="33.6" lower_limit="18" upper_limit="55"/>
                    <measurement group_id="B3" value="34.7" lower_limit="18" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="88"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Average Daily Wear Time</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.5" lower_limit="8" upper_limit="18"/>
                    <measurement group_id="B2" value="13.4" lower_limit="8" upper_limit="24"/>
                    <measurement group_id="B3" value="13.4" lower_limit="8" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean logMAR Contact Lens Visual Acuity</title>
        <description>Visual acuity (VA) will be reported as letters read correctly, and the letters read will be converted to logarithm of the minimum angle of resolution (logMAR) acuity. The participant will read rows of letters on a standard LogMAR chart until the participant misses 3 letters on a row with 5 letters. The total number of correct letters will be recorded. A decrease in the number of correct letters indicates a decrease in visual acuity. Acuity will be averaged across visits.</description>
        <time_frame>3 months</time_frame>
        <population>The per protocol population consisted of randomized without important (major) protocol deviations. It is a subset of the participants randomized and treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Kalifilcon A Daily Disposable Contact Lenses</title>
            <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Kalifilcon A Daily Disposable Contact Lenses: Contact lens</description>
          </group>
          <group group_id="O2">
            <title>Biotrue ONEday Daily Disposable Contact Lenses</title>
            <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Biotrue ONEday Daily Disposable Contact Lenses: Contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Mean logMAR Contact Lens Visual Acuity</title>
          <description>Visual acuity (VA) will be reported as letters read correctly, and the letters read will be converted to logarithm of the minimum angle of resolution (logMAR) acuity. The participant will read rows of letters on a standard LogMAR chart until the participant misses 3 letters on a row with 5 letters. The total number of correct letters will be recorded. A decrease in the number of correct letters indicates a decrease in visual acuity. Acuity will be averaged across visits.</description>
          <population>The per protocol population consisted of randomized without important (major) protocol deviations. It is a subset of the participants randomized and treated.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="240"/>
                <count group_id="O2" value="254"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.066" spread="0.0034"/>
                    <measurement group_id="O2" value="-0.060" spread="0.0032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Participants With Slit Lamp Findings Greater Than Grade 2</title>
        <description>During an examination of both eyes without lenses, graded slit lamp findings will be assessed for each eye using Grades 0 (none), 1 (trace), 2 (mild), 3 (moderate), and 4 (severe). Using only the non-missing observations from all visits without imputation, each eye will be classified with respect to findings greater than Grade 2 at any visit (Absent or Present). Epithelial edema, epithelial microcysts, corneal staining, limbal Injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be evaluated.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Kalifilcon A Daily Disposable Contact Lenses</title>
            <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Kalifilcon A Daily Disposable Contact Lenses: Contact lens</description>
          </group>
          <group group_id="O2">
            <title>Biotrue ONEday Daily Disposable Contact Lenses</title>
            <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Biotrue ONEday Daily Disposable Contact Lenses: Contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Participants With Slit Lamp Findings Greater Than Grade 2</title>
          <description>During an examination of both eyes without lenses, graded slit lamp findings will be assessed for each eye using Grades 0 (none), 1 (trace), 2 (mild), 3 (moderate), and 4 (severe). Using only the non-missing observations from all visits without imputation, each eye will be classified with respect to findings greater than Grade 2 at any visit (Absent or Present). Epithelial edema, epithelial microcysts, corneal staining, limbal Injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be evaluated.</description>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="248"/>
                <count group_id="O2" value="254"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <desc>Adverse events were not coded, therefore source vocabulary is not applicable.</desc>
      <group_list>
        <group group_id="E1">
          <title>Kalifilcon A Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb kalifilcon A daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Kalifilcon A Daily Disposable Contact Lenses: Contact lens</description>
        </group>
        <group group_id="E2">
          <title>Biotrue ONEday Daily Disposable Contact Lenses</title>
          <description>Participants will wear Bausch + Lomb Biotrue ONEday daily disposable contact lenses for at least 8 hours per day at least 5 days per week for approximately 3 months. Participants will be provided with Bausch + Lomb Sensitive Eyes Drops for use as needed during the study and lens cases for return of worn study lenses to the Investigator at the end of the study.&#xD;
Biotrue ONEday Daily Disposable Contact Lenses: Contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="124"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="127"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="124"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="124"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <phone>(585) 338-6399</phone>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

